Related Experiment Video
Updated: Jun 17, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Beyond the scalpel: targeting hedgehog in skin cancer prevention
1Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland, USA. rudin@jhmi.edu
Abstract:
This perspective places the article by Tang et al. in this issue of the journal (beginning on page 25) in the context of recent work defining the hedgehog signaling pathway as a central etiologic factor and as a therapeutic target in basal cell cancer. Tang et al. show that inhibition of cyclooxygenase activity, either genetically (in a relevant mouse model) or pharmacologically (in the mouse and in patients highly predisposed to develop basal cell skin cancers), may suppress basal cell carcinogenesis. This new study of cyclooxygenase inhibition, together with recent data on the efficacy of hedgehog pathway inhibition, offers new hope for patients at a high risk for basal cell cancer.
Insights
Inhibition of cyclooxygenase activity may suppress basal cell carcinogenesis. This finding offers new hope for basal cell cancer patients, alongside hedgehog pathway inhibition strategies.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Basal cell cancer (BCC) is a prevalent skin malignancy.
- The hedgehog signaling pathway is a key factor in BCC etiology and a therapeutic target.
- Cyclooxygenase (COX) activity's role in BCC has been investigated.
Discussion:
- Tang et al. demonstrate that inhibiting cyclooxygenase activity can suppress basal cell carcinogenesis.
- This inhibition was effective both genetically in mouse models and pharmacologically in mice and humans predisposed to BCC.
- The findings link COX activity to BCC development, suggesting it as a potential therapeutic target.
Key Insights:
- Cyclooxygenase inhibition, via genetic or pharmacological means, shows promise in suppressing basal cell carcinogenesis.
- This research provides a new perspective on BCC development and potential treatment avenues.
- Combined strategies targeting both cyclooxygenase and hedgehog pathways may enhance BCC treatment efficacy.
Outlook:
- Further research into cyclooxygenase inhibitors for BCC prevention and treatment is warranted.
- This study opens avenues for combination therapies for high-risk BCC patients.
- The findings contribute to a deeper understanding of skin cancer development and therapeutic interventions.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Prevention
Some...
Cancer Prevention
Some...
Clinical Applications of Epidermal Stem Cells

